Chemoinformaics analysis of P-Menthan-Trans-2,5-Diol
| Molecular Weight | 172.268 | nRot | 1 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
| Exact Molecular Weight | 172.146 | nRing | 1 |
| Solubility: LogS | -1.634 | nHRing | 0 |
| Solubility: LogP | 1.373 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 31.6399 |
| nHD | 2 | BPOL | 20.0641 |
| QED | 0.628 |
| Synth | 3.96 |
| Natural Product Likeliness | 2.081 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.034 |
| HIA | 0.01 |
| CACO-2 | -4.527 |
| MDCK | 0.000049 |
| BBB | 0.794 |
| PPB | 0.417307 |
| VDSS | 1.362 |
| FU | 0.428176 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.398 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.821 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.742 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.266 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.397 |
| CL | 14.208 |
| T12 | 0.521 |
| hERG | 0.027 |
| Ames | 0.035 |
| ROA | 0.086 |
| SkinSen | 0.163 |
| Carcinogencity | 0.072 |
| EI | 0.859 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.905617 |